Arc vs Injective

Compare Arc and Injective on TVL, fees, revenue and activity to understand how these projects stack up.

$622.72M
Arc is an open layer 1 blockchain developed by Circle, the issuer of USDC, and designed for stablecoin finance. It uses USDC as its native gas token so that fees are paid in dollars with predictable costs, offers sub-second deterministic finality and is EVM-compatible for developers. Arc targets payments, foreign exchange, capital markets and tokenized assets, with an integrated stablecoin FX engine and optional privacy features for institutional use cases. It connects natively to Circle's products such as USDC, EURC and the Cross-Chain Transfer Protocol.
View Full Page
$16.34M
Injective is a Cosmos‑SDK Layer‑1 with on‑chain order books, zero‑gas trading and a frequent batch auction that mitigates MEV. Its built‑in Ethereum bridge lets users bring ERC‑20s without custodial risk, and the WasmX module supports CosmWasm smart contracts. INJ holders can stake or participate in governance that controls upgrades like the 2024 Volan hard fork which added liquid staking.
View Full Page

Key Metrics Comparison

Arc
TVL
$622.72M
24h Volume
$20.92M
24h Fees
$91.9K
24h Revenue
$6.5K
30d Fees
$4.21M
30d Revenue
$292.4K
7d TVL Change
+16.53%
Dominance
0.70%
Injective
TVL
$16.34M
24h Volume
$3.02M
24h Fees
$301
24h Revenue
$137
30d Fees
$67.3K
30d Revenue
$31.4K
7d TVL Change
+16.10%
Dominance
0.02%

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

TVL Share

Share of combined TVL

TVL Share
Arc
97.4%
Injective
2.6%

Volume Share

Share of combined 24h volume

Volume Share
Arc
87.4%
Injective
12.6%

Fees Share

Share of combined 24h fees

Fees Share
Arc
99.7%
Injective
1.0%

Revenue Share

Share of combined 24h revenue

Revenue Share
Arc
97.9%
Injective
2.1%

7d TVL Performance

TVL change over last 7 days

7d TVL Performance
Arc
16.53%
Injective
16.10%

Dominance

Market dominance by TVL

Dominance
Arc
0.7%
Injective
0.0%
TVL Comparison
Arc
Injective